- NCT00004129
Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
Phase 1Unknown - NCT00004918
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
Phase 1Completed - NCT00015938
S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
Phase 2Completed - NCT00040885
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
Phase 3Completed - NCT00022737
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia
Phase 3Completed - NCT00032032
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase 1Completed - NCT00032188
Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer
Phase 2Completed - NCT00006105
Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
Phase 2Completed - NCT00023829
Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Phase 3Completed - NCT00002916
Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer
Phase 2Completed - NCT00002746
Interleukin-2 in Treating Patients With Myelodysplastic Syndrome
Phase 1Completed - NCT00023686
Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer
Phase 3Completed - NCT00002798
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Phase 3Completed - NCT00019682
Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma
Phase 3Completed - NCT00004212
DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
Phase 1Completed - NCT00049088
Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors
Phase 1Terminated - NCT00004876
Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer
Phase 2Completed - NCT00031733
Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
Phase 2Completed - NCT00028730
Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer
Phase 2Completed - NCT00023751
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
Phase 2Completed - NCT00004871
Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase 1Completed - NCT00031629
Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Phase 2Completed - NCT00004866
DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix
Phase 2Completed - NCT00006110
Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer
Phase 2Completed - NCT00004867
Positron Emission Tomography in Determining Stage of Esophageal Cancer
Not ApplicableCompleted - NCT00005879
LY353381 in Preventing Breast Cancer in Women With Hyperplasia
Phase 2Completed - NCT00002608
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Phase 2Completed - NCT00039390
Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00002706
Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
Phase 3Completed - NCT00031577
Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
Phase 1Terminated - NCT00025428
Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma
Phase 3Completed - NCT00024193
Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma
Phase 2Unknown - NCT00004181
Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia
Phase 2Completed - NCT00006234
Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone
Phase 1Completed - NCT00049712
Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma
Phase 1Completed - NCT00049699
VNP40101M in Treating Patients With Advanced or Metastatic Cancer
Phase 1Completed - NCT00049686
VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
Phase 1Completed - NCT00049673
Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma
Phase 3Completed - NCT00049634
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
Phase 1Completed - NCT00003607
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
Phase 3Completed - NCT00049608
Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors
Phase 1Terminated - NCT00049582
Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Phase 1Terminated - NCT00049465
Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
Not ApplicableCompleted - NCT00049452
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
Phase 3Completed - NCT00049400
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
Phase 1Completed - NCT00049374
Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2Completed - NCT00049296
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Phase 1Completed - NCT00002762
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
Completed - NCT00049257
Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 2Completed - NCT00049218
Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1Completed - NCT00049192
Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Phase 2Completed - NCT00049179
S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Phase 2Completed - NCT00049166
Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
Phase 1Completed - NCT00049127
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase 1Completed - NCT00049075
Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
Phase 2Completed - NCT00049062
Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer
Phase 2Completed - NCT00049023
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Phase 1Completed - NCT00048984
Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
Completed - NCT00048971
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
Completed - NCT00048958
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active Not Recruiting - NCT00049010
Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
Not ApplicableCompleted - NCT00047385
National Lung Screening Trial (NLST) Screening
Phase 3Completed - NCT00047346
Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction
Phase 1Completed - NCT00047333
Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
Phase 2Terminated - NCT00047307
Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
Phase 1Completed - NCT00047281
Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
Phase 2Completed - NCT00047255
Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
Phase 3Completed - NCT00047242
UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00047229
Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
Phase 2Completed - NCT00047216
Tipifarnib in Treating Patients With Recurrent Bladder Cancer
Phase 2Completed - NCT00047203
Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2Completed - NCT00047190
Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
Phase 2Completed - NCT00047060
Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
Phase 1Completed - NCT00047047
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00047034
E7389 in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00047008
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Phase 3Completed - NCT00046943
Atrasentan in Treating Patients With Prostate Cancer
Phase 3Completed - NCT00046917
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00046904
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
Phase 3Completed - NCT00049517
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
Phase 3Completed - NCT00027963
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
Phase 3Completed - NCT00046865
Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer
Phase 3Completed - NCT00022048
Bevacizumab in Treating Patients With Myelodysplastic Syndrome
Phase 1Completed - NCT00046826
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
Phase 2Completed - NCT00026299
Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
Phase 1Completed - NCT00016432
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
Phase 3Completed - NCT00014092
Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery
Phase 2Completed - NCT00045734
Imatinib Mesylate in Treating Patients With Recurrent Meningioma
Phase 2Completed - NCT00045708
A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
Phase 1Completed - NCT00045695
Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
Phase 2Completed - NCT00045682
CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Phase 2Completed - NCT00045669
Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
Phase 2Completed - NCT00045604
Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1Completed - NCT00045591
Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
Phase 2Terminated - NCT00019487
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
Phase 2Completed - NCT00045539
Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
Phase 2Completed - NCT00045526
Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
Phase 2Completed - NCT00045513
Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
Phase 1Completed - NCT00045500
UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma
Phase 1Completed - NCT00045487
Erlotinib in Treating Patients With Advanced Kidney Cancer
Phase 2Completed